Where IgM immunoblot (≥2 of 3 bands) is reported
Also listed as: Tier 2 — early disease
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Lyme Disease | ↑ elevated | Uninfected | Early disseminated (<30 days IgM) | CDC 2024 |
Frequently asked questions
In which conditions is IgM immunoblot (≥2 of 3 bands) altered?
In the OSMF atlas IgM immunoblot (≥2 of 3 bands) is reported in Lyme Disease. It is elevated in 1 across 1 entries.
Is there a standard clinical test for IgM immunoblot (≥2 of 3 bands)?
The atlas entries for IgM immunoblot (≥2 of 3 bands) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal IgM immunoblot (≥2 of 3 bands) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.